NCT00202228View on ClinicalTrials.gov

Lactate Metabolism Study in HIV Infected Persons

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2008

Study Completion Date

September 30, 2011

Conditions
HIV InfectionsAIDSLactic AcidosisLipodystrophy
Interventions
DRUG

cofactor supplementation (thiamine, riboflavin, L-carnitine)

Thiamine: 50 mg po od; Riboflavin: 100 mg po od; L-carnitine: 990 mg po bid.

Trial Locations (1)

K7L 3N6

Queen's University, Kingston

All Listed Sponsors
collaborator

Ontario HIV Treatment Network

NETWORK

lead

Queen's University

OTHER

NCT00202228 - Lactate Metabolism Study in HIV Infected Persons | Biotech Hunter | Biotech Hunter